Cyclosporine A induced changes to plasma and erythrocyte antioxidant defences

Redox Report

Volumn 10, Issue 1, 2005, Pages 2-8

  Fletcher, Louise A ^a   Fassett, Robert G ^b   Richards, Ross S ^a   Coombes, Jeff S ^c  

^a CHARLES STURT UNIVERSITY   (Australia)

^b LAUNCESTON GENERAL HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antioxidants; Cyclosporine A; Eythrocytes; Free radicals; Plasma; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; CREATININE; CYCLOSPORIN A; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CREATININE; CYCLOSPORINE; ERYTHROCYTES; FEMALE; MALONDIALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 24744456670     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100005X21543     Document Type: Article

References (53)

1. Kendrick E. Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis 2001; 38 (Suppl 6): S36-S43.
2. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
3. Oflaz H, Turkmen A, Kazancioglu R et al. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 2003; 17: 212-216.
4. Barenbrock M, Kosch M, Joster E, Kisters K, Rahn KH, Hausberg M. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J H Hypertens 2002; 20: 79-84.
5. Toth KM, Clifford DP, Berger EM, White CW, Repine JE. Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J Clin Invest 1984; 74: 292-295.
6. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL. Erythrocyte antioxidant enzyme systems protect cultured endothelial cells against oxidant damage. Biochem Mol Biol Int 1998; 46: 857-865.
7. May JM, Qu Z, Cobb CE. Extracellular reduction of the ascorbate free radical by human erythrocytes. Biochem Biophys Res Commun 2000; 267: 118-123.
8. Nuttall SL, Kendall MJ, Martin U. Antioxidant therapy for the prevention of cardiovascular disease. QJM 1999; 92: 239-244.
9. Hatherill JR, Till GO, Ward PA. Mechanisms of oxidant-induced changes in erythrocytes. Agents Actions 1991; 32: 351-358.
10. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416.
11. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J Nutr 2001; 131: S366-S368.
12. Cristol JP, Maggi MF, Vela C, Descomps B, Mourad G. Lipid metabolism and oxidative stress in renal transplantation: implications for chronic rejection. Transplant Proc 1996; 28: 2820-2821.
13. Cristol JP, Vela C, Maggi MF, Descomps B, Mourad G. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 1998; 65: 1322-1328.
14. Simic-Ogrizovic S, Simic T, Reljic Z et al. Markers of oxidative stress after renal transplantation. Transplant Int 1998; 11 (Suppl 1): S125-S129.
15. Hussein O, Rosenblat M, Refael G, Aviram M. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation 1997; 63: 679-685.
16. Taylor JE, Scott N, Hill A et al. Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 1993; 55: 500-504.
17. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20: 698-702.
18. Santori L, Rastelli M, Arena B, Morleo MA. Cyclosporine: update on pharmacology, analytical techniques and therapeutic monitoring. Boll Chim Farm 1997; 136: 577-588.
19. Granot E, Shemesh P, Rivkin L, Kohen R. Plasma and low-density lipoprotein lipid peroxidation in cyclosporine A-treated children after liver transplant. Transplant Proc 1998; 30: 4057-4059.
20. John S, Schmieder RE. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 2000; 18: 363-374.
21. Zhang W, Li JL, Hosaka M et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci USA 2000; 97: 9765-9770.
22. Serino F, Grevel J, Napoli KL, Kahan BD, Strobel HW. Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc 1994; 26: 2916-2917.
23. Ahmed SS, Strobel HW, Napoli KL, Grevel J. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J Pharmacol Exp Ther 1993; 265: 1047-1054.
24. Wolf A, Trendelenburg CF, Diez-Fernandez C et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp T Ther 1997; 280: 1328-1334.
25. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 1995; 47: 927-934.
26. Kumar KV, Naidu MU, Shifow AA, Prayag A, Ratnakar KS. Melatonin: an antioxidant protects against cyclosporine-induced nephrotoxicity. Transplantation 1999; 67: 1065-1068.
27. Durak I, Karabacak HI, Buyukkocak S et al. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 1998; 78: 207-211.
28. Duruibe VA, Okonmah A, Blyden GT. Effect of cyclosporin on rat liver and kidney glutathione content. Pharmacology 1989; 39: 205-212.
29. Hirose M, Kuroda Y. Reinforcement of cyclosporin A-induced red cell destruction by superoxide. Tokushima J Exp Med 1994; 41: 65-70.
30. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-514.
31. Lohr GW, Waller HD. Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU. (ed) Methods of Enzymatic Analysis. New York: Academic Press, 1974; 636-643.
32. Slaughter MR, O'Brien PJ. Fully-automated spectrophotometric method for measurement of antioxidant activity of catalase. Clin Biochem 2000; 33: 525-534.
33. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem 1997; 43: 562-568.
34. Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys 1998; 35: 184-188.
35. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979; 32: 2143-2149.
36. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412.
37. Taibi G, Nicotra CM. Development and validation of a fast and sensitive chromatographic assay for all-trans-retinol and tocopherols in human serum and plasma using liquid-liquid extraction. J Chromatogr B: Anal Technol Biomed Life Sci 2002; 780: 261-267.
38. Sim AS, Salonikas C, Naidoo D, Wilcken DE. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B: Anal Technol Biomed Life Sci 2003; 785: 337-344.
39. Varghese Z, Fernando RL, Turakhia G et al. Oxidizability of low-density lipoproteins from neoral and tacrolimus-treated renal transplant patients. Transplant Proc 1998; 30: 2043-2046.
40. Granot E, Elinav H, Kohen R. Markers of oxidative stress in cyclosporine-treated and tacrolimus-treated children after liver transplantation. Liver Transpl 2002; 8: 469-475.
41. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57 (5 Suppl): S787-S797.
42. Taniguchi N. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. Adv Clin Chem 1992; 29: 1-59.
43. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
44. Longoni B, Boschi E, Dementis GC, Ratto GM, Mosca F. Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels. FASEB J 2001; 15: 731-740.
45. 1A receptor in cyclosporine induced hypertensive rats. Eur J Pharmacol 1993; 248: 341-344.
46. McGrath LT, Treacy R, McClean E, Brown JH. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin Chim Acta 1997; 264: 1-12.
47. Elinav H, Kohen R, Granot E. Plasma oxidizability and plasma carbonyls, markers of oxidative stress, in liver transplant patients. Transplant Proc 2001; 33: 2918-2919.
48. Varghese Z, Fernando RL, Turakhia G et al. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int 1999; 71: S137-S140.
49. Yoshimura R, Yoshimura N, Nakatani T et al. The effects of cyclosporin on renal microsomal cytochrome P-450 systems. Clin Nephrol 1993; 40: 339-345.
50. Massafra C, Gioia D, De Felice C, Muscettola M, Longini M, Buonocore G. Gender-related differences in erythrocyte glutathione peroxidase activity in healthy subjects. Clin Endocrinol 2002; 57: 663-667.
51. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1738.
52. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940-946.
53. Parra Cid T, Conejo Garcia JR, Carballo Alvarez F, de Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003; 189: 99-111.